Davis Capital Management

Position in JNJ — Johnson & Johnson

CIK 1811806 JACKSONVILLE, FL

Position in JNJ

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,503,128

+$13,752 QoQ

Shares Held

9,856

-3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.64%

of 13F equity value

Holder Rank

#2,160

of 4,676 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davis Capital Management holds $6,297,182 across 10 Drug Manufacturers - General names. JNJ ranks #1 (39.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	9,856	$2,503,128
2	AMGN	Amgen Inc	6,521	$2,361,384
3	ABBV	AbbVie Inc.	5,302	$1,334,195
4	LLY	ELI LILLY & Co	61	$73,165
5	GILD	Gilead Sciences, Inc.	80	$10,107
6	MRK	Merck & Co., Inc.	58	$7,453
7	BMY	Bristol Myers Squibb Co	59	$3,399
8	PFE	Pfizer Inc	137	$3,298

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,503,128	9,856	-3.2%	Shares	Sole	2026-07-16
2026-03-31	$2,489,376	10,184	-3.6%	Shares	Sole	2026-04-16
2025-12-31	$2,187,254	10,569	-3.2%	Shares	Sole	2026-01-28
2025-09-30	$2,024,786	10,920	+3.6%	Shares	Sole	2025-10-21
2025-03-31	$1,748,285	10,542	+0.7%	Shares	Sole	2025-04-11
2024-12-31	$1,513,448	10,465	+0.3%	Shares	Sole	2025-01-17
2024-09-30	$1,690,609	10,432	+4.4%	Shares	Sole	2024-10-01
2024-06-30	$1,460,284	9,991	+9.3%	Shares	Sole	2024-07-02
2024-03-31	$1,446,489	9,144	+6.2%	Shares	Sole	2024-04-05
2023-12-31	$1,350,001	8,613	+23.6%	Shares	Sole	2024-02-14
2020-06-30	$980,050	6,969	-4.6%	Shares	Sole	2020-07-29
2020-03-31	$958,298	7,308	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.